Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease

American Journal of Physiology - Cell Physiology

Volumn 285, Issue 5 54-5, 2003, Pages

  Sotgia, Federica ^a,b   Woodman, Scott E ^a   Bonuccelli, Gloria ^a,b   Capozza, Franco ^a   Minetti, Carlo ^b   Scherer, Philipp E ^a   Lisanti, Michael P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Caveolin 3; Muscle cell caveolae; Muscular dystrophy

Indexed keywords

ARGININE; CAVEOLIN 3; CREATINE KINASE; GLUTAMINE; MUTANT PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DISTAL MYOPATHY; GENE MUTATION; GOLGI COMPLEX; HYPERCKEMIA; IDIOPATHIC DISEASE; LIMB GIRDLE MUSCULAR DYSTROPHY; MOUSE; MUSCLE CELL; MUSCLE DISEASE; NONHUMAN; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; WILD TYPE;

ANIMALIA;

EID: 0142020889     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00166.2003     Document Type: Article

References (50)

1. Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V, Torbergsen T, Lee YA, Nothen MM, Wienker TF, Malin JP, Propping P, Reis A, Mortier W, Jentsch TJ, Vorgerd M, and Kubisch C. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 28: 218-219, 2001.
2. Carbone I, Bruno C, Sotgia F, Bado M, Broda P, Masetti E, Panella A, Zara F, Bricarelli FD, Cordone G, Lisanti MP, and Minetti C. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 54: 1373-1376, 2000.
3. Chang WJ, Ying Y, Rothberg K, Hooper N, Turner A, Gambliel H, De Gunzburg J, Mumby S, Gilman A, and Anderson RGW. Purification and characterization of smooth muscle cell caveolae. J Cell Biol 126: 127-138, 1994.
4. Corley-Mastick C, Brady MJ, and Saltiel AR. Insulin stimulates the tyrosine phosphorylation of caveolin. J Cell Biol 129: 1523-1531, 1995.
5. Crosbie RH, Yamada H, Venzke DP, Lisanti MP, and Campbell KP. Caveolin-3 is not an essential component of the dystrophin glycoprotein complex. FEBS Lett 427: 279-282, 1998.
6. Dietzen DJ, Hastings WR, and Lublin DM. Caveolin is palmitoylated on multiple cysteine residues: palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem 270: 6838-6842, 1995.
7. Engelman JA, Wycoff CC, Yasuhara S, Song KS, Okamoto T, and Lisanti MP. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272: 16374-16381, 1997.
8. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou HJ, Kneitz B, Edelmann W, and Lisanti MP. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J Biol Chem 276: 21425-21433, 2001.
9. Galbiati F, Razani B, and Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell 106: 403-411, 2001.
10. Galbiati F, Volonte' D, Minetti C, Chu JB, and Lisanti MP. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). J Biol Chem 274: 25632-25641, 1999.
11. Glenney JR. The sequence of human caveolin reveals identity with VIP 21, a component of transport vesicles. FEBS Lett 314: 45-48, 1992.
12. Glenney JR. Tyrosine phosphorylation of a 22 kD protein is correlated with transformation with Rous sarcoma virus. J Biol Chem 264: 20163-20166, 1989.
13. Glenney JR and Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in RSV-transformed fibroblasts. Proc Natl Acad Sci USA 89: 10517-10521, 1992.
14. Herrmann R, Straub V, Blank M, Kutzick C, Franke N, Jacob EN, Lenard HG, Kroger S, and Voit T. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet 9: 2335-2340, 2000.
15. Koleske AJ, Baltimore D, and Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92: 1381-1385, 1995.
16. Kurzchalia T, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, and Simons K. VIP 21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J Cell Biol 118: 1003-1014, 1992.
17. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, and Lisanti MP. Evidence for a regulated interaction between hetero-trimeric G proteins and caveolin. J Biol Chem 270: 15693-15701, 1995.
18. Li S, Song KS, and Lisanti MP. Expression and characterization of recombinant caveolin: purification by poly-histidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J Biol Chem 271: 568-573, 1996.
19. Lisanti MP, Scherer PE, Vidugiriene J, Tang ZL, Hermanoski-Vosatka A, Tu YH, Cook RF, and Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126: 111-126, 1994.
20. Lisanti MP, Tang ZL, and Sargiacomo M. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae, J Cell Biol 123: 595-604, 1993.
21. Lisanti MP, Tang ZT, Scherer P, and Sargiacomo M. Caveolae purification and GPI-linked protein sorting in polarized epithelia. Methods Enzymol 250: 655-668, 1995.
22. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, Nonaka I, Arahata K, and Brown RH Jr. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 10: 1761-1766, 2001.
23. Merlini L, Carbone I, Capanni C, Sabatelli P, Tortorelli S, Sotgia F, Lisanti MP, Bruno C, and Minetti C. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry 73: 65-67, 2002.
24. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco P, Egeo A, Donati MA, Volonte' D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, and Zara F. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 18: 365-368, 1998.
25. Murata M, Peranen J, Schreiner R, Weiland F, Kurzchalia T, and Simons K. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 92: 10339-10343, 1995.
26. Okamoto T, Schlegel A, Scherer PE, and Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
27. Palade GE and Bruns RR. Structural modification of plasmalemma vesicles. J Cell Biol 37: 633-649, 1968.
28. Parton RG. Caveolae and caveolins. Curr Opin Cell Biol 8: 542-548, 1996.
29. Parton RG, Way M, Zorzi N, and Stang E. Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol 136: 137-154, 1997.
30. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou HJ, Kneitz B, Lagaud G, Christ GJ, Edelmann W, and Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
31. Robbins SM, Quintrell NA, and Bishop MJ. Myristoylation and differential palmitoylation of the HCK protein tyrosine kinases govern their attachment to membranes and association with caveolae. Mol Cell Biol 15: 3507-3515, 1995.
32. Rothberg KG, Heuser JE, Donzell WC, Ying Y, Glenney JR, and Anderson RGW. Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682, 1992.
33. Sargiacomo M, Scherer PE, Tang ZL, Casanova JE, and Lisanti MP. In vitro phosphorylation of caveolin-rich membrane domains: identification of an associated serine kinase activity as a casein kinase II-like enzyme. Oncogene 9: 2589-2595, 1994.
34. Sargiacomo M, Scherer PE, Tang ZL, Kubler E, Song KS, Sanders MC, and Lisanti MP. Oligomeric structure of caveolin: Implications for caveolae membrane organization. Proc Natl Acad Sci USA 92: 9407-9411, 1995.
35. Sargiacomo M, Sudol M, Tang ZL, and Lisanti MP. Signal transducing molecules and GPI-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122: 789-807, 1993.
36. Scherer PE, Lederkremer GZ, Williams S, Fogliano M, Baldini G, and Lodish HF. Cab45, a novel (Ca2+)-binding protein localized to the Golgi lumen. J Cell Biol 133: 257-268, 1996.
37. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, and Lisanti W. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable heterooligomeric complex in vivo. J Biol Chem 272: 29337-29346, 1997.
38. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Corley-Mastick C, and Lodish HF. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol 127: 1233-1243, 1994.
39. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, and Lisanti MP. Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93: 131-135, 1996.
40. Scherer PE, Tang ZL, Chun MC, Sargiacomo M, Lodish HF, and Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: identification and epitope mapping of an isoform-specific monoclonal antibody probe, J Biol Chem 270: 16395-16401, 1995.
41. 2+-ATPase, and inositol triphosphate receptor. Proc Natl Acad Sci USA 92: 1759-1763, 1995.
42. Schroeder R, London E, and Brown D. Interactions between saturated acyl chains confer detergent resistance on lipids and GPI-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci USA 91: 12130-12134, 1994.
43. Smart E, Ying YS, Conrad P, and Anderson RGW. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol 127: 1185-1197, 1994.
44. Song KS, Scherer PE, Tang ZL, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, and Lisanti MP. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-15165, 1996.
45. Song KS, Tang ZL, Li S, and Lisanti MP. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homotypic caveolin-caveolin interactions. J Biol Chem 272: 4398-4403, 1997.
46. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, and Lisanti MP. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 275: 38048-38058, 2000.
47. Tang ZL, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, and Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271: 2255-2261, 1996.
48. Tateyama M, Aoki M, Nishino I, Hayashi YK, Sekiguchi S, Shiga Y, Takahashi T, Onodera Y, Haginoya K, Kobayashi K, Iinuma K, Nonaka I, Arahata K, and Itoyama Y. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 58: 323-325, 2002.
49. Vorgerd M, Ricker K, Ziemssen F, Kress W, Goebel HH, Nix WA, Kubisch C, Schoser BG, and Mortier W. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 57: 2273-2277, 2001.
50. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1: 445-458, 1955.